Therapeutic Potential of Ayush 64 in Covid-19: An Ayurvedic Perspective
Article pdf download
Publication Certificate


Ayush64, Kiratatikta, Saptaparna, Kutaki, Latakaranja

How to Cite

POTBHARE, B. (2021). Therapeutic Potential of Ayush 64 in Covid-19: An Ayurvedic Perspective . Ayurlog: National Journal of Research in Ayurved Science, 9(02). Retrieved from


In the human history, a medical emergency has emerged in the form of Covid-19 disease. Coronavirus disease 2019 (COVID-19), is caused by severe acute respiratory syndrome which has become pandemic. The medical treatment of Covid-19 consists of symptomatic management and oxygen supply, with ventilation for patients with acute respiratory failure. There is no specific treatment for Covid-19. Globally, efforts are being made to verify the efficacy of traditional system of medicines to fight against the Covid-19. Ayurveda, the traditional system of Indian medicine, has also number of herbal medicines which can be used to treat the systems of Covid-19. The Ayush-64 drug is used to treat Malaria (Visama Jvara) and it has been developed by CCRAS, Ministry of AYUSH, Govt. of India. Contents of Ayush 64 drug are: Saptaparna (Alstonia scholaris R. Br.) Bark Aqueous Extract 100 mg; Katuki (Picrorhiza kurroa Royle ex. Benth) Root do 100 mg; Kirata tikta (Swertia Chirata (Pexb ex. Karst) Whole plant do 100 mg; and Kaberuka (Caesalpinia crista Linn.) Seed powder 200 mg. This paper intends to understand the drug actions of contents of Ayush 64 according to Ayurvedic point of view.
Article pdf download
Publication Certificate

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website and online filled (uploaded) form



Download data is not yet available.